InvestSMART

Recce Pharmaceuticals Ltd (ASX: RCE) - Announcements

Current share price for RCE : $0.360 0.015 (4%)+

ASX company news and announcements for Recce Pharmaceuticals Ltd (RCE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Recce Pharmaceuticals Ltd (RCE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Recce Pharmaceuticals Ltd (RCE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Recce Pharmaceuticals Ltd (RCE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$110 Appendix 2A 27 Feb 2020 5:28PM $0.385 $0.360 fallen by 6.49%
$110 Half Yearly Report and Accounts 27 Feb 2020 5:23PM $0.385 $0.360 fallen by 6.49%
$110 Positive Efficacy Data in Kidney/UTI infections animal model 14 Feb 2020 10:02AM $0.440 $0.360 fallen by 18.18%
$110 Positive Data from RECCE 327 Antibiotic Safety Studies 10 Feb 2020 10:07AM $0.390 $0.360 fallen by 7.69%
$110 Appendix 4C and Commentary 31 Jan 2020 3:46PM $0.360 $0.360 fallen by 0%
$110 Cleansing Statement 16 Jan 2020 5:12PM $0.335 $0.360 risen by 7.46%
$110 Appendix 2A 16 Jan 2020 5:07PM $0.335 $0.360 risen by 7.46%
$110 Change of Director's Interest Notice 20 Dec 2019 3:51PM $0.330 $0.360 risen by 9.09%
$110 Change of Director's Interest Notice 19 Dec 2019 6:00PM $0.310 $0.360 risen by 16.13%
$110 Cleansing Statement 19 Dec 2019 5:50PM $0.310 $0.360 risen by 16.13%
$110 Appendix 3B 19 Dec 2019 5:47PM $0.310 $0.360 risen by 16.13%
$110 Corporate Presentation - December 2019 4 Dec 2019 2:53PM $0.260 $0.360 risen by 38.46%
$110 Constitution 29 Nov 2019 4:17PM $0.275 $0.360 risen by 30.91%
$110 Positive Data for RECCE 327 in MRSA Burns Wound Infection 27 Nov 2019 9:55AM $0.260 $0.360 risen by 38.46%
$110 Results of Meeting 25 Nov 2019 1:35PM $0.260 $0.360 risen by 38.46%
$110 Trading Halt 25 Nov 2019 9:08AM $0.260 $0.360 risen by 38.46%
$110 Opening Address at 2019 World Antibiotic Resistance Congress 8 Nov 2019 9:16AM $0.295 $0.360 risen by 22.03%
$110 Appendix 4C and Commentary 31 Oct 2019 2:00PM $0.265 $0.360 risen by 35.85%
$110 Notice of Annual General Meeting/Proxy Form 25 Oct 2019 4:03PM $0.260 $0.360 risen by 38.46%
$110 White Paper on Recce Synthetic Polymer Antibiotics 23 Oct 2019 9:45AM $0.275 $0.360 risen by 30.91%
$110 Change in substantial holding 16 Oct 2019 5:53PM $0.265 $0.360 risen by 35.85%
$110 Cleansing Statement 16 Oct 2019 5:31PM $0.265 $0.360 risen by 35.85%
$110 Notice under ASX Listing Rule 3.10.5A 16 Oct 2019 5:23PM $0.265 $0.360 risen by 35.85%
$110 Appendix 3B 16 Oct 2019 5:17PM $0.265 $0.360 risen by 35.85%
$110 Recce Completes Raising of $6.76 million 10 Oct 2019 10:06AM $0.315 $0.360 risen by 14.29%

476 - 500 of 727 results

Page 20 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.